J&J Said to Raise Actelion Takeover Offer as Talks Advance


Johnson & Johnson, the world's biggest maker of health-care products, raised its takeover offer for Actelion Ltd. as negotiations with Europe's largest biotech firm progress, according to people familiar with the matter. J&J significantly increased its offer from an earlier bid of about 246 Swiss francs a share, or $26 billion, which the Swiss company rejected as too low, said the people, asking not to be identified because the deliberations are private.



from Biotech News